✦ LIBER ✦

Diastasis recti abdominis in HIV-infected men with lipodystrophy

✍ Scribed by PD Blanchard

Book ID: 111063194
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 103 KB
Volume: 6
Category: Article
ISSN: 1464-2662
DOI: 10.1111/j.1468-1293.2005.00264.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PP218 ASSOCIATION OF LIPODYSTROPHY AND O

PP218 ASSOCIATION OF LIPODYSTROPHY AND OXIDATIVE STRESS BIOMARKERS IN HIV-INFECTED MEN

✍ H. Vassimon; A.A. Machado; J.P. Monteiro; R. Deminice; A. Jordao Jr. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Atherogen lipid profile in HIV-1-infecte

Atherogen lipid profile in HIV-1-infected patients with lipodystrophy syndrome

✍ Patrick Mercié; Serge Tchamgoué; Rodolphe Thiébaut; Jean-François Viallard; Isab 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 74 KB

Hypermetabolism and altered substrate ox

Hypermetabolism and altered substrate oxidation in HIV-infected patients with lipodystrophy

✍ Helena S. Vassimon; Francisco José Albuquerque de Paula; Alcyone A. Machado; Jac 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 237 KB

PP351 BIOELETRICAL IMPEDANCE AS A TOOL T

PP351 BIOELETRICAL IMPEDANCE AS A TOOL TO ASSESS BODY COMPOSITION IN HIV INFECTED MEN WITH LIPODYSTROPHY SYNDROME

✍ H. Vassimon; A.A. Machado; F.J.A. Paula; J.P. Monteiro; A.A. Jordão 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Lipodystrophy and metabolic syndrome in

Lipodystrophy and metabolic syndrome in HIV-infected patients treated with antiretroviral therapy

✍ Vicente Estrada; María Teresa Martínez-Larrad; José Luis González-Sánchez; Noemí 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Approach to Dyslipidemia, Lipodystrophy,

Approach to Dyslipidemia, Lipodystrophy, and Cardiovascular Risk in Patients with HIV Infection

✍ J. Gregory Troll 📂 Article 📅 2010 🏛 Current Science Inc. 🌐 English ⚖ 130 KB

There is a significant prevalence (20%–80% depending on the population and the study) of lipid disorders and other cardiovascular risk factors in people living with HIV infection. This review focuses on HIV and HIV treatment–associated metabolic and cardiovascular concerns, including dyslipidemias,